Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa

Neurology

Volumn 68, Issue 5, 2007, Pages 350-355

  Wong, M H ^a,f   Robertson, K ^b   Nakasujja, N ^d   Skolasky, R ^c   Musisi, S ^d   Katabira, E ^d   McArthur, J C ^c   Ronald, A ^e   Sacktor, N ^c  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MAKERERE UNIVERSITY   (Uganda)

^e UNIVERSITY OF MANITOBA   (Canada)

^f UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DEMENTIA; DEMOGRAPHY; FEMALE; FUNCTIONAL ASSESSMENT; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOGISTIC REGRESSION ANALYSIS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; RISK FACTOR; UGANDA;

ADULT; AFRICA SOUTH OF THE SAHARA; COMORBIDITY; DEMENTIA; EMPLOYMENT; FEMALE; HIV INFECTIONS; HUMANS; MALE; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SOCIOECONOMIC FACTORS; UGANDA;

EID: 33846572876     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000252811.48891.6d     Document Type: Article

References (33)

1. Brodt HR, Kamps BS, Gute P, Knupp B, Staszewski S, Helm EB. Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS 1997;11:1731-1738.
2. Kumarasamy N, Solomon S, Chaguturu SK, et al. The changing natural history of HIV disease: before and after the introduction of generic antiretroviral therapy in southern India. Clin Infect Dis 2005;41:1525-1528.
3. Sacktor N, Lyles RH, Skolasky R, et al. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology 2001;56:257-260.
4. Albert SM, Marder K, Dooneief G, et al. Neuropsychologic impairment in early HIV infection. A risk factor for work disability. Arch Neurol 1995;52:525-530.
5. Hinkin CH, Castellon SA, Durvasula RS, et al. Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology 2002;59:1944-1950.
6. Gifford AL, Bormann JE, Shively MJ, Wright BC, Richman DD, Bozzette SA. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr 2000;23:386-395.
7. Liu H, Golin CE, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med 2001;134:968-977.
8. Wainberg MA, Friedland G. Public health implications of antiretroviral therapy and HIV drug resistance. JAMA 1998;279:1977-1983.
9. McArthur JC, Brew BJ, Nath A. Neurological complications of HIV infection. Lancet Neurol 2005;4:543-555.
10. Sacktor NC, Lyles RH, Skolasky RL, et al. Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men. Multicenter AIDS Cohort Study (MACS). Neurology 1999;52:1640-1647.
11. Sacktor NC, Skolasky RL, Lyles RH, Esposito D, Selnes OA, McArthur JC. Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors. J Neurovirol 2000;6:84-88.
12. Sacktor N, Nakasujja N, Skolasky R, et al. Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa. Neurology 2006;67:311-314.
13. Robertson KR, Robertson WT, Ford S, et al. Highly active antiretroviral therapy improves neurocognitive functioning. J Acquir Immune Defic Syndr 2004;36:562-566.
14. Miller EN, Selnes OA, McArthur JC, et al. Neuropsychological performance in HIV-1-infected homosexual men: the Multicenter AIDS Cohort Study (MACS). Neurology 1990;40:197-203.
15. Maj M, D'Elia L, Satz P, et al. Evaluation of two new neuropsychological tests designed to minimize cultural bias in the assessment of HIV-1 seropositive persons: a WHO study. Arch Clin Neuropsychol 1993;8:123-135.
16. Rey A. L'examen psychological dans les cas d'encephalopathie traumatique. Arch Psychol 1941;28:286-340.
17. Maj M, Satz P, Janssen R, et al. WHO Neuropsychiatric AIDS study, cross-sectional phase II. Neuropsychological and neurological findings. Arch Gen Psychiatry 1994;51:51-61.
18. Dugbartey AT, Townes BD, Mahurin RK. Equivalence of the Color Trails Test and Trail Making Test in nonnative English-speakers. Arch Clin Neuropsychol 2000;15:425-431.
19. Reitan R. Validity of the Trail Making test as an indicator of organic brain damage. Percept Mot Skills 1958;8:271-276.
20. Klove H. Clinical neuropsychology. Med Clin North Am 1963;47:1647-1658.
21. Stern Y, McDermott MP, Albert S, et al. Factors associated with incident human immunodeficiency virus-dementia. Arch Neurol 2001;58:473-479.
22. Smith A. Symbol Digit Modalities Test. Los Angeles: Western Psychological Service, 1982.
23. Price RW, Brew BJ. The AIDS dementia complex. J Infect Dis 1988;158:1079-1083.
24. Janssen RS, Nwanyanwu OC, Selik RM, Stehr-Green JK. Epidemiology of human immunodeficiency virus encephalopathy in the United States. Neurology 1992;42:1472-1476.
25. Portegies P, Enting RH, de Gans J, et al. Presentation and course of AIDS dementia complex: 10 years of follow-up in Amsterdam, The Netherlands. AIDS 1993;7:669-675.
26. Sacktor N, McDermott MP, Marder K, et al. HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol 2002;8:136-142.
27. Belec L, Martin PM, Vohito MD, Gresenguet G, Tabo A, Georges AJ. Low prevalence of neuro-psychiatric clinical manifestations in central African patients with acquired immune deficiency syndrome. Trans R Soc Trop Med Hyg 1989;83:844-846.
28. Howlett WP, Nkya WM, Mmuni KA, Missalek WR. Neurological disorders in AIDS and HIV disease in the northern zone of Tanzania. AIDS 1989;3:289-296.
29. Perriens JH, Mussa M, Luabeya MK, et al. Neurological complications of HIV-1-seropositive internal medicine inpatients in Kinshasa, Zaire. J Acquir Immune Defic Syndr 1992;5:333-340.
30. Childs EA, Lyles RH, Selnes OA, et al. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology 1999;52:607-613.
31. Valcour V, Shikuma C, Shiramizu B, et al. Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort. Neurology 2004;63:822-827.
32. Mbulaiteye SM, Mahe C, Whitworth JA, et al. Declining HIV-1 incidence and associated prevalence over 10 years in a rural population in south-west Uganda: a cohort study. Lancet 2002;360:41-46.
33. Kamya MR, Nsubuga P, Grant RM, Hellman N. The high prevalence of genital herpes among patients with genital ulcer disease in Uganda. Sex Transm Dis 1995;22:351-354.